Smiths Industries continues acquisition strategy with £136 million purchase of Graseby
This article was originally published in Clinica
Smiths Industries is to pay £136 million ($220 million) for fellow UK company Graseby, in a move aimed at expanding Smiths Industries' range of hospital products and enhancing its distribution network. It will pay 211p a share, a 41% premium on closing share prices on August 4, the day before the transaction was announced. Shares in Graseby, which markets medical devices and monitoring equipment, leapt 39% to 207.5p at close on August 5.
You may also be interested in...
Commissioner Robert Califf wants Janet Woodcock to improve food operations and processes, but lawmakers question whether she is the best overseer for the area.
Medtech Insight talked with XACT Robotics’ executive chairman Harel Gadot about plans for the FDA-cleared ACE robotic system and market opportunities. See what Gadot said about the market opportunity here.
Private Company Edition: The global accelerator has new commitments from HHS and the Wellcome Trust. Also, Apollo buys into Sofinnova Partners with an up to €1bn investment, Castle Creek raised $124.6m in private funding this year in lieu of an IPO and Remix closed a $70m series B round.